TMC eyes 30% revenue from fertility business


(From left) TMC Women’s Specialist Holdings Sdn Bhd, IVF Technologies Sdn Bhd, Thomson TCM Sdn Bhd, TMC Biotech Sdn Bhd, and TMC Care Sdn Bhd CEO Irene Kwan Yee Man, TMC Life Sciences Bhd executive director Barry Kan Kheong Ng, chairman Professor Emeritus Datuk Dr Khalid Abdul Kadir, group CEO Wan Nadiah Wan Mohd Abdullah Yaakob and group CFO Jimmy Wong Yu Chee.

PETALING JAYA: TMC Life Sciences Bhd aims to grow its fertility business to contribute 30% to total group revenue for the financial year ending June 30,2021 (FY21), from the current 17%.

This will be partly driven by the group’s new fertility centre in Puchong, which is expected to commence operations this May.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

TMC , Nadiah , revenue , fertility business , coronavirus , hospital ,

   

Next In Business News

Industrial projects look increasingly attractive
Dutch Lady’s balancing act amid escalating costs
Demand for co-working space remains resilient
Fed dampens hopes for rate cut
F&N to use cost management measures
Changing office space requirements
Naza makes entry into green economy
CapBay aims to provide financing to more SMEs
New initiative for infrastructure needs in Perak
Ocean Fresh seeks ACE Market listing

Others Also Read